Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
β Scribed by Louise R. Rodino-Klapac; Amanda M. Haidet; Janaiah Kota; Chalonda Handy; Brian K. Kaspar; Jerry R. Mendell
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 932 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Safinamide is an Ξ±βaminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an addβon to dopamine agonist (DA) therapy in earlyβstage PD. In this 24βweek, doubleβblind study, patients with early PD receiving a stable dose of a single DA were randomized to
## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4Ψ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets